Everest Medicines announces the launch of VELSIPITY® in the Guangdong-Hong Kong-Macau Greater Bay Area
October 25, 2024 | 06:40
Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that, through the "Hong Kong and Macau Medicine and Equipment Connect" policy.
Mobile Version